SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001144204-17-023308
Filing Date
2017-04-28
Accepted
2017-04-28 17:16:50
Documents
5

Document Format Files

Seq Description Document Type Size
1 424B5 v465435_424b5.htm 424B5 350593
2 GRAPHIC image_001.jpg GRAPHIC 18808
3 GRAPHIC logo-cantorfitzgerald.jpg GRAPHIC 3547
4 GRAPHIC logo-cantorfitzgerald2.jpg GRAPHIC 6743
5 GRAPHIC logo.jpg GRAPHIC 5221
  Complete submission text file 0001144204-17-023308.txt   399441
Mailing Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921
Business Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921 908-443-1860
Matinas BioPharma Holdings, Inc. (Filer) CIK: 0001582554 (see all company filings)

IRS No.: 463011414 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-217106 | Film No.: 17797091
SIC: 2834 Pharmaceutical Preparations